Amherst, NY, United States of America

Md Tafazzal Hossain


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Md Tafazzal Hossain: Innovator in Anticancer and Anti-inflammatory Research

Introduction

Md Tafazzal Hossain is a notable inventor based in Amherst, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic potential. His work focuses on iodonium analogs that exhibit anticancer and anti-inflammatory properties.

Latest Patents

Md Tafazzal Hossain holds 2 patents that highlight his innovative research. His latest patents include "Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof." These patents disclose novel iodonium analogs that have demonstrated anticancer and anti-inflammatory activity, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Md Tafazzal Hossain has worked with reputable organizations, including Starks Associates Inc. and the United States of America as represented by the Department of Health. His experience in these institutions has allowed him to contribute to significant research initiatives and develop impactful solutions in healthcare.

Collaborations

Md Tafazzal Hossain has collaborated with esteemed colleagues such as James Halpern Doroshow and Prabhakar Risbood. These partnerships have enriched his research endeavors and fostered a collaborative environment for innovation.

Conclusion

Md Tafazzal Hossain is a distinguished inventor whose work in developing iodonium analogs has the potential to make a significant impact in the fields of cancer treatment and inflammation management. His contributions to medicinal chemistry are noteworthy and reflect his dedication to improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…